Price to Earning AnalysisPrice to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
About Price to EarningGenerally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
|Compare to competition|
Based on latest financial disclosure the price to earning indicator of Virtus LifeSci Biotech Products ETF is roughly 18.03 times. This is much higher than that of the BioShares family, and significantly higher than that of Sector category, The Price to Earning for all etfs is over 1000% lower than the firm.
Virtus LifeSci Biotech Fundamental Drivers Relationships0.09 of Price to Book per Price to Earning. The ratio of Price to Earning to Price to Book for Virtus LifeSci Biotech Products ETF is roughly 10.86
The fund invests 99.95% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.